The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vignali, D. A. A.
Right arrow Articles by Vignali, K. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vignali, D. A. A.
Right arrow Articles by Vignali, K. M.
The Journal of Immunology, 1999, 162: 1431-1439.
Copyright © 1999 by The American Association of Immunologists

Profound Enhancement of T Cell Activation Mediated by the Interaction Between the TCR and the D3 Domain of CD41

Dario A. A. Vignali2,*,{dagger} and Kate M. Vignali*

* Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38101; and {dagger} Department of Pathology, University of Tennessee Medical Center, Memphis, TN 38163

CD4 plays an important role in the activation and development of CD4+ T cells. This is mediated via its bivalent interaction with MHC class II molecules and the TCR:CD3 complex through p56lck. Recent studies have implicated a third site of interaction between the membrane-proximal extracellular domains of CD4 and the TCR. Due to these multiple interactions, direct evidence for the functional importance of this extracellular association has remained elusive. Furthermore, the residues that mediate this interaction are unknown. In this study, we analyzed the function of 61 CD4 mutants. Alanine substitution of just 2 residues, either Q114/F182 or F182/F201, which are partially buried and located close to the D2/D3 interface, completely abrogated CD4 function. Direct evidence for the functional importance of TCR:CD4.D3 interaction was obtained using an anti-CD3fos:anti-CD4jun-bispecific Ab. Surprisingly, it induced strong T cell activation in hybridomas transfected with cytoplasmic-tailless CD4, despite the lack of association with either p56lck or MHC class II molecules. However, this effect was completely abrogated with the CD4 mutants Q114A/F182A or F182A/F201A. These data demonstrate that TCR:CD4.D3 interaction can have a profound effect on T cell activation and obviates the need for receptor oligomerization.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Maekawa, B. Schmidt, B. Fazekas de St. Groth, Y.-H. Sanejouand, and P. J. Hogg
Evidence for a Domain-Swapped CD4 Dimer as the Coreceptor for Binding to Class II MHC.
J. Immunol., June 1, 2006; 176(11): 6873 - 6878.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Szymczak and D. A. A. Vignali
Plasticity and Rigidity in Adaptor Protein-2-Mediated Internalization of the TCR:CD3 Complex
J. Immunol., April 1, 2005; 174(7): 4153 - 4160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Workman and D. A. A. Vignali
Negative Regulation of T Cell Homeostasis by Lymphocyte Activation Gene-3 (CD223)
J. Immunol., January 15, 2005; 174(2): 688 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. L. La Gruta, H. Liu, S. Dilioglou, M. Rhodes, D. L. Wiest, and D. A. A. Vignali
Architectural Changes in the TCR:CD3 Complex Induced by MHC:Peptide Ligation
J. Immunol., March 15, 2004; 172(6): 3662 - 3669.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Workman, K. J. Dugger, and D. A. A. Vignali
Cutting Edge: Molecular Analysis of the Negative Regulatory Function of Lymphocyte Activation Gene-3
J. Immunol., November 15, 2002; 169(10): 5392 - 5395.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xiong, P. Kern, H.-C. Chang, and E. L. Reinherz
T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4
J. Biol. Chem., February 16, 2001; 276(8): 5659 - 5667.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.